Schroder Investment Management Group
ACAD icon

Schroder Investment Management Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Schroder Investment Management Group’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-71,643
Closed -$1.53M – 1144
2025
Q3 		$1.53M Buy
+71,643
New +$1.69M ﹤0.01% 972
2025
Q2 		– Sell
-272,882
Closed -$4.66M – 1153
2025
Q1 		$4.66M Buy
272,882
+4,848
+2% +$88.1K ﹤0.01% 768
2024
Q4 		$4.47M Sell
268,034
-264,938
-50% -$4.28M ﹤0.01% 783
2024
Q3 		$8.36M Buy
532,972
+400,110
+301% +$6.67M 0.01% 696
2024
Q2 		$2.16M Hold
132,862
– – ﹤0.01% 919
2024
Q1 		$2.46M Buy
132,862
+71,160
+115% +$1.76M ﹤0.01% 894
2023
Q4 		$1.93M Buy
+61,702
New +$1.47M ﹤0.01% 915

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return